The final step of the transduction pathway is the activation of gene transcription, which is driven by kinase cascades leading to changes in the activity of many transcription factors. Among these latter, PEA3/E1AF, ER81/ ETV1, and ERM, members of the well conserved PEA3 group from the Ets family are involved in these processes. We show here that protein kinase A (PKA) increases the transcriptional activity of human ERM and human ETV1, through a Ser residue situated at the edge of the ETS DNA-binding domain. PKA phosphorylation does not directly affect the ERM transactivation domains but does affect DNA binding activity. Unphosphorylated wild-type ERM bound DNA avidly, whereas after PKA phosphorylation it did so very weakly. Interestingly, S367A mutation significantly reduced the ERMmediated transcription in the presence of the kinase, and the DNA binding of this mutant, although similar to that of unphosphorylated wild-type protein, was insensitive to PKA treatment. Mutations, which may mimic a phosphorylated serine, converted ERM from an efficient DNA-binding protein to a poor DNA binding one, with inefficiency of PKA phosphorylation. The present data clearly demonstrate a close correlation between the capacity of PKA to increase the transactivation of ERM and the drastic down-regulation of the binding of the ETS domain to the targeted DNA. What we thus demonstrate here is a relatively rare transcription activation mechanism through a decrease in DNA binding, probably by the shift of a non-active form of an Ets protein to a PKA-phosphorylated active one, which should be in a conformation permitting a transactivation domain to be active.The regulation of gene expression by specific signal transduction pathways is tightly connected to cell phenotype. Several molecules involved in intracellular signaling are encoded by oncogenes, which directly link their potential aberrant expression to cell transformation or altered proliferation. The final step of the transduction pathway is the activation of nuclear transcription factors. For example, the cyclic-AMPand calcium-regulated nuclear factor is activated through the protein kinase A (PKA) 1 pathway via phosphorylation. The differential phosphorylation of transcription factors by signal transduction pathways such as the mitogen-activated protein kinase (MAPK) plays a crucial role in the regulation of gene expression. This is the case for the c-fos gene expression, which is regulated by the binding to DNA of the Elk/TCF factor after phosphorylation through the MAPK pathway. The activation of MAPK cascades leads to changes in the activity of many Ets factors such as Elk/TCF (for reviews, see Refs. 1 and 2).The Ets family of transcription factors, which includes more than 30 members from sponges to humans (for reviews, see Refs. 2 and 3), has been involved in both tumorigenesis and a number of developmental processes. They all contain the ETS domain (4), a domain of 85 amino acids structured as a winged helix-turn-helix structure and responsible for DNA inding to the sp...